[144] Intapp, Inc. SEC Filing
Insider Form 144 filing for Intapp, Inc. (INTA) reports a proposed sale of 104,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $4,453,280.00. The shares were acquired and paid for on 08/25/2025 by exercise of stock options and payment in cash. The filing lists the issuer's total shares outstanding as 82,120,030, and the planned sale is scheduled for 08/25/2025 on NASDAQ. The filing also discloses several recent sales by John T Hall and 10b5-1 plans between 05/27/2025 and 08/22/2025, totaling multiple transactions including an 80,000-share sale on 08/18/2025 with gross proceeds of $3,408,152.00.
- Transaction transparency: Filing discloses acquisition date, nature of acquisition (exercise of options), payment method (cash), broker, and aggregate market value.
- Use of 10b5-1 plans: Several sales are identified as 10b5-1, indicating prearranged trading plans for some transactions.
- No plan adoption date disclosed: The filing lists 10b5-1 sales but does not provide specific plan adoption dates in the remarks section.
- Potential concentration of sales by a single insider: Multiple sales by John T Hall are disclosed over a short period, which could be viewed as noteworthy by investors.
Insights
TL;DR Insider exercised options and intends to sell 104,000 shares on 08/25/2025; multiple prior 10b5-1 and direct sales were disclosed.
The filing documents a routine Form 144 notice where 104,000 shares (aggregate value $4.45M) were acquired by exercise and are proposed for sale the same day. The shares represent approximately 0.13% of the reported 82,120,030 outstanding shares, indicating the transaction is small relative to company capitalization. The filing also provides a clear record of recent sales by John T Hall and associated 10b5-1 trades executed between 05/27/2025 and 08/22/2025, with disclosed gross proceeds for each trade. From a market-impact perspective, the single proposed sale is unlikely to be material to overall equity supply based on the outstanding share count.
TL;DR The filer used option exercise and 10b5-1 sales; disclosures conform to Rule 144 and reference trading-plan sales.
The notice states the shares to be sold were acquired by exercise of stock options on 08/25/2025 and paid in cash the same day, and it lists earlier sales including trades governed by Rule 10b5-1. The signature representation language about no undisclosed material information and the plan adoption/instruction fields are present but contain no additional explanatory remarks. The filing appears procedurally complete for a Form 144 submission and documents reliance on 10b5-1 where indicated.